The JRC has printed a Methodological Guidance that gives useful tips around the most commonly encountered challenges when applying the frameworkSummary Tirzepatide is a whole new molecule able to managing glucose blood amounts by combining the dual agonism of Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-Like Peptide-one (GLP-one)